VSTO
VISTA OUTDOOR INC
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$4.3M
Inst. Activity0 buys / 14 sells
SEC Reports1
Recent Activity
Feb 28, 2026
SEC
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and Schwab — fully exited their positions in
INST-CLUSTER — Impact 7/10
Inst.
STATE STREET CORP — EXIT
0 shares ($0.00)
Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — EXIT
0 shares ($0.00)
Analyst Ratings
2Strong Buy
4Buy
6Hold
0Sell
0Strong Sell
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BARCLAYS PLC | $4.3M | — |
1 institutional holders with $4.3M total value (108,962 shares) as of 2025-Q3. Top holders: BARCLAYS.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BARCLAYS PLC | 108,962 | $4.3M | 100.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| STATE STREET CORP | EXIT | 2,180,898 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | EXIT | 871,505 | 0 | -100.0% | $0.00 | 2024-Q4 |
| Invesco Ltd. | EXIT | 303,640 | 0 | -100.0% | $0.00 | 2024-Q4 |
| DIMENSIONAL FUND ADVISORS LP | EXIT | 3,478,452 | 0 | -100.0% | $0.00 | 2024-Q4 |
| VANGUARD GROUP INC | EXIT | 4,989,132 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BlackRock, Inc. | EXIT | 8,885,428 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BALYASNY ASSET MANAGEMENT L.P. | EXIT | 970,852 | 0 | -100.0% | $0.00 | 2024-Q4 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | EXIT | 439,123 | 0 | -100.0% | $0.00 | 2024-Q4 |
| Assenagon Asset Management S.A. | EXIT | 338,941 | 0 | -100.0% | $0.00 | 2024-Q4 |
| Pacer Advisors, Inc. | EXIT | 3,145,716 | 0 | -100.0% | $0.00 | 2024-Q4 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | EXIT | 330,470 | 0 | -100.0% | $0.00 | 2024-Q4 |
| Verition Fund Management LLC | EXIT | 316,494 | 0 | -100.0% | $0.00 | 2024-Q4 |
| GAMCO INVESTORS, INC. ET AL | EXIT | 337,455 | 0 | -100.0% | $0.00 | 2024-Q4 |
| MORGAN STANLEY | EXIT | 554,362 | 0 | -100.0% | $0.00 | 2024-Q4 |
| BALYASNY ASSET MANAGEMENT L.P. | DOUBLED | 9,191 | 970,852 | +10463.1% | $38.0M | 2024-Q3 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | NEW | — | 439,123 | — | $17.2M | 2024-Q3 |
| Verition Fund Management LLC | DOUBLED | 7,683 | 316,494 | +4019.4% | $12.4M | 2024-Q3 |
| GABELLI FUNDS LLC | ADD | 88,592 | 125,665 | +41.8% | $4.9M | 2024-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 156,236 | 85,670 | -45.2% | $3.4M | 2024-Q3 |
| VICTORY CAPITAL MANAGEMENT INC | ADD | 48,893 | 81,884 | +67.5% | $3.2M | 2024-Q3 |
| CITIGROUP INC | TRIM | 155,312 | 78,167 | -49.7% | $3.1M | 2024-Q3 |
| Centiva Capital, LP | DOUBLED | 20,424 | 45,000 | +120.3% | $1.8M | 2024-Q3 |
| ROYAL BANK OF CANADA | TRIM | 96,269 | 38,560 | -59.9% | $1.5M | 2024-Q3 |
| Focus Partners Wealth | TRIM | 68,220 | 34,241 | -49.8% | $1.3M | 2024-Q3 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 21,214 | 31,645 | +49.2% | $1.2M | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 50% buy across 12 analysts — 2 strong buy, 4 buy, 6 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jan 1, 2025 | 2 | 4 | 6 | 0 | 0 | 50% | |
| Dec 1, 2024 | 2 | 4 | 6 | 0 | 0 | 50% | |
| Nov 1, 2024 | 2 | 4 | 6 | 0 | 0 | 50% | |
| Oct 1, 2024 | 3 | 4 | 5 | 0 | 0 | 58% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.